94 related articles for article (PubMed ID: 8212013)
21. The toxic shock syndrome toxin-1 induces anergy in human T cells in vivo.
Mahlknecht U; Herter M; Hoffmann MK; Niethammer D; Dannecker GE
Hum Immunol; 1996 Jan; 45(1):42-5. PubMed ID: 8655359
[TBL] [Abstract][Full Text] [Related]
22. Delineation by use of specific monoclonal antibodies of the T-cell receptor and major histocompatibility complex interaction sites on the superantigen toxic shock syndrome toxin 1.
Shimonkevitz R; Boen E; Malmstrom S; Brown E; Hurley JM; Kotzin BL; Matsumura M
Infect Immun; 1996 Apr; 64(4):1133-9. PubMed ID: 8606069
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
Moseley AB; Huston DP
J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
[TBL] [Abstract][Full Text] [Related]
24. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
Wahlsten JL; Mills CD; Ramakrishnan S
J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
[TBL] [Abstract][Full Text] [Related]
25. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Brogan PA; Shah V; Klein N; Dillon MJ
Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of rat spleen cells by staphylococcal enterotoxins.
Holbrook MR; Young KE; Gibbon LG; Webster CA; Tranter HS; Arbuthnott JP; Todd I
FEMS Immunol Med Microbiol; 1993 Aug; 7(2):169-74. PubMed ID: 8401429
[TBL] [Abstract][Full Text] [Related]
27. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: II. B cell activation.
Morris DL; Holsapple MP
Immunopharmacology; 1991; 21(3):171-81. PubMed ID: 1917439
[TBL] [Abstract][Full Text] [Related]
28. Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways.
Fukushima H; Hirano T; Oka K
Eur J Pharmacol; 2007 Sep; 570(1-3):222-8. PubMed ID: 17610867
[TBL] [Abstract][Full Text] [Related]
29. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells.
Yoo BS; Boverhof DR; Shnaider D; Crawford RB; Zacharewski TR; Kaminski NE
Toxicol Sci; 2004 Feb; 77(2):272-9. PubMed ID: 14600275
[TBL] [Abstract][Full Text] [Related]
30. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
Micusan VV; Mercier G; Bhatti AR; Reiser RF; Bergdoll MS; Oth D
Immunology; 1986 Jun; 58(2):203-8. PubMed ID: 3486824
[TBL] [Abstract][Full Text] [Related]
31. Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes.
Poindexter NJ; Schlievert PM
J Infect Dis; 1985 Jan; 151(1):65-72. PubMed ID: 3871225
[TBL] [Abstract][Full Text] [Related]
32. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: I. Similarities to Staphylococcus aureus Cowan Strain I (SAC) in the in vitro T-dependent antibody response.
Morris DL; Jordan SD; Holsapple MP
Immunopharmacology; 1991; 21(3):159-69. PubMed ID: 1917438
[TBL] [Abstract][Full Text] [Related]
33. Human peripheral gammadelta T cells potentiate the early proinflammatory cytokine response to staphylococcal toxic shock syndrome toxin-1.
Kalyan S; Chow AW
J Infect Dis; 2004 May; 189(10):1892-6. PubMed ID: 15122526
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.
Hofer MF; Newell K; Duke RC; Schlievert PM; Freed JH; Leung DY
Proc Natl Acad Sci U S A; 1996 May; 93(11):5425-30. PubMed ID: 8643591
[TBL] [Abstract][Full Text] [Related]
35. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on responses to lipopolysaccharide (LPS) by isolated murine B-cells.
Morris DL; Karras JG; Holsapple MP
Immunopharmacology; 1993; 26(2):105-12. PubMed ID: 8282534
[TBL] [Abstract][Full Text] [Related]
36. 2,3,7,8-tetrachlorodibenzo-p-dioxin selectively enhances spontaneous IgE production in B cells from atopic patients.
Kimata H
Int J Hyg Environ Health; 2003 Oct; 206(6):601-4. PubMed ID: 14626908
[TBL] [Abstract][Full Text] [Related]
37. Suppression of immunoglobulin-secreting cells from human peripheral blood by toxic-shock-syndrome toxin-1.
Poindexter NJ; Schlievert PM
J Infect Dis; 1986 Apr; 153(4):772-9. PubMed ID: 3512737
[TBL] [Abstract][Full Text] [Related]
38. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
Norton SD; Schlievert PM; Novick RP; Jenkins MK
J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
[TBL] [Abstract][Full Text] [Related]
39. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
[TBL] [Abstract][Full Text] [Related]
40. Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells.
Chatila T; Wood N; Parsonnet J; Geha RS
J Immunol; 1988 Feb; 140(4):1250-5. PubMed ID: 2830336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
